Notice of Closed Meeting, 67943 [2024-18857]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 163 / Thursday, August 22, 2024 / Notices
department and other public health and
community partners; and (4) provide
technical assistance to field staff.
The National Foundation for the
Centers for Disease Control &
Prevention, Inc (CDCF) is the only entity
that can carry out this work because
they have earned the trust of health
departments and their partners and have
been supporting them with this very
need by strengthening the public health
infrastructure, systems and services for
overdose prevention and surveillance
efforts for five years through CDC–RFA–
OT18–1802. CDCF has a proven track
record of successfully recruiting,
training, retaining, and building
capacity of the public health workforce
to support overdose prevention
programs such as Overdose Data to
Action (OD2A) and the Overdose
Response Strategy (ORS)and has
established a clear process for
infrastructure and capacity building
needs. CDCF is widely recognized by
public health entities and partners and
is the only organization that was created
by Congress to mobilize philanthropic
and private-sector resources to support
the Centers for Disease Control and
Prevention’s (CDC) critical health
protection work which has been critical
in allowing this program to support
capacity building within state, tribal,
local, and territorial health departments
and partnership development across all
facets of public health.
ddrumheller on DSK120RN23PROD with NOTICES1
Summary of the Award
Recipient: National Foundation for
the Centers for Disease Control &
Prevention, Inc. (CDCF).
Purpose of the Award: The purpose of
this award is to support a national
organization that will work with state,
local and territorial health departments
in their implementation of evidencebased overdose prevention and response
activities that support OD2A in States,
OD2A: LOCAL, and ORS recipients
through staffing support and enhance
their partnerships with public safety
entities. CDCF will also provide training
and technical assistance opportunities
to field staff to enhance their capacity to
support the implementation of
evidence-based overdose prevention
and response activities, and engage in
various evaluation, reporting,
communication, and dissemination
activities to demonstrate the reach,
success, and effectiveness of these
capacity building activities.
Amount of Award: $17,000,000 in
Federal Fiscal Year (FFY) 2024 funds,
with a total estimated $68,000,000 for
the four-year period of performance,
subject to availability of funds.
VerDate Sep<11>2014
17:28 Aug 21, 2024
Jkt 262001
Authority: This program is authorized
under section 392(b)(1) and (2) of the
Public Health Service (PHS) Act (42
U.S.C. 280b–0(b)(1) and (2)) and section
301(a) of the PHS Act (42 U.S.C. 241(a)).
Period of Performance: September 30,
2024, through September 29, 2028.
Dated: August 14, 2024.
Terrance Perry,
Acting Director, Office of Grants Services,
Centers for Disease Control and Prevention.
[FR Doc. 2024–18782 Filed 8–21–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 18–812, NIOSH Member Conflict
Review.
Date: October 29, 2024.
Time: 1 p.m.–4 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1095 Willowdale Road, Morgantown,
West Virginia 26505. Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
67943
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–18857 Filed 8–21–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10767]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by September 23,
2024.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
SUMMARY:
E:\FR\FM\22AUN1.SGM
22AUN1
]]>Agencies
[Federal Register Volume 89, Number 163 (Thursday, August 22, 2024)]
[Notices]
[Page 67943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18857]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--PAR 18-812, NIOSH Member Conflict
Review.
Date: October 29, 2024.
Time: 1 p.m.-4 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, Office of Extramural Programs, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, 1095 Willowdale Road, Morgantown, West Virginia
26505. Telephone: (304) 285-5951; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-18857 Filed 8-21-24; 8:45 am]
BILLING CODE 4163-18-P
